New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
09:01 EDTEXASFDA confirms date for Exact Sciences' advisory committee
Exact Sciences announced that the U.S. Food and Drug Administration has confirmed by notice in the Federal Register that its Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee will review the premarket approval application for the company’s Cologuard stool-DNA-based, non-invasive colorectal cancer screening test on March 27.
News For EXAS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
15:32 EDTEXASExact Sciences announces Norton Healthcare to adopt Cologuard
Exact Sciences announced Norton Healthcare is the first healthcare system in Kentucky to offer Cologuard, the first and only FDA-approved noninvasive stool DNA screening test for colorectal cancer. Cologuard makes it easy for average risk patients 50 years and older to get screened at their convenience and in the privacy and comfort of their own home without having to worry about taking time off work to prepare for an invasive procedure. “Norton Healthcare is proud to be the first healthcare provider in Kentucky to offer this important new advancement that can help increase screening compliance for colon cancer,” said Dr. Thomas Woodcock, an Oncology Specialist with the Norton Healthcare Cancer Institute. “The decision to offer this at-home screening tool reflects the commitment of the Norton Cancer Institute to lead the way in innovative cancer care and prevention.”

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use